MORPHINE sulfate, 10mg, prolonged-release caps.

STD DORAMORP1CS

Valid Article

Former Code(s): -X DORAMORP1TS- DORAZFR0544
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N02AA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Substance listed as Narcotic Drug or Psychotropic Substance, and as precursors. Other substances may be subject to restrictions according to national regulations. These substances require an import permit from the country of destination when ordering.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

MORPHINE prolonged-release

Therapeutic Action

Centrally acting opioid analgesic

Morphine sustained-release (MSR)

Indications

Severe and persistent pain

Treatment of patients in reconstructive surgery programme and burns that require long term therapy and a stable blood level

Instructions for use

Prolonged-(sustained) release morphine is supplied in capsule or tablet depending on the manufacturer.

Do not crush or chew the capsules (they may be opened and the contents mixed with food).

It is recommended to simultaneously order naloxone injectable (specific opioid antagonist).

Distribution to be controlled: narcotics register or supervision of amounts in and out, and storage under lock and key (Cf Introduction: Narcotic and psychotropic medicines under international control)

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity